Enaltus (US rights to BioCorneum) Overview
- Status
- Acquired/Merged
- Latest Deal Type
- Asset Purch.
- Financing Rounds
- 1
Enaltus (US rights to BioCorneum) General Information
Description
Rights of a pharmaceutical product. The asset includes distribution rights for BioCorneum, an advanced silicone gel scar management products of the company Enaltus in the United States. The product is a quick drying, patented silicone gel that creates an invisible, breathable, flexible, and waterproof silicone sheet over scars.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Office
- United States
Enaltus (US rights to BioCorneum) Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Enaltus (US rights to BioCorneum)‘s full profile, request access.
Request a free trialEnaltus (US rights to BioCorneum) Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Enaltus (US rights to BioCorneum)‘s full profile, request access.
Request a free trial